维普期刊资源整合服务平台（V6.5）

173篇 您的检索式：作者名="Stohl W"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4^+ CD25^+ regulatory cells显示文摘	Zheng SG Wang JH Stohl W	2006	J Immunol2006，176，6：	1
2	B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: Longitudinal observations显示文摘	Stohl W Metyas S Tan SM	2003	Arthritis Rheum2003，48，12：	1
3	B lymophcyte stimulator overexpression in patients with systemic lupus erythematosus 显示文摘	Stohl W Metyas S Tan S M	2003	Arthritis Rheum2003，48，12：	1
4	B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus:longitudinal observations 显示文摘	Stohl W Metyas S Tan SM	2003	Arthritis Rheum2003，48，12：	1
5	MHC class Ⅱ- independent and -dependent T cell expansion and B cell hyperactivity in vi vo in mice deficient in CD152 (CTLA 4)显示文摘	Stohl W Xu D Kim KS	2004	Int Immunol2004，16，：	1
6	Pationts with inflammatory arthritic diseases harbor eievatcd serum and synovial t:luid levels of free and immune-complexed glucose-6 phosphate isomerase (G6PI) 显示文摘	Scallme M Stohl W Benoit V	2006	Biochem Biophys Res Commun2006，349，2：	1
7	Therapeutic targeting of the BAFF/April axis in systemic lupus erythematosus显示文摘	Stohl W	2014	Expert Opin Ther Targets2014，18，4：	1
8	Superantigen-driven,CD8 + T cell-mediated down-regulation: CD95 ( Fas ) -dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells 显示文摘	Stohl W Lynch DH Starling GC	1998	J Immunol1998，161，32：	1
9	B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus:longitudinal observations显示文摘	Stohl W Metyas S Tan SM	2003	Arthritis Rheum2003，48，12：	1
10	Safety,pharmacokinetic and pharmacodynamic results of a phase single and double dose-escalation study of lymphoStat-B(human monoclonal antibody to BLyS)in SLE patients显示文摘	Furie R Stohl W Ginzler E	2003	Arthritis Rheum2003，48，9：	1
11	Belimumab(BmAb)reduces SLE disease activity and demonstrates durable bioactivity at 76 weeks显示文摘	Wallace DJ Lisse J Stohl W	2006	Arthritis Rheum2006，54，9：	1
12	Systemic lupus erythematosus: a blissless disease of too much BLyS (B lymphocyte stimulator) protein 显示文摘	Stohl W	2002	Curr Opin Rheumatol2002，14，5：	1
13	Patients with inflammalory arthritic disease harbor elevated serum and synovial fluid levels of free and immune-complexed glucose 6-phospbate isomerase(G6PI)显示文摘	Sclaller M Stohl W Benoit V	2006	Biochem Biophys Res Commun2006，349，2：	1
14	Systemic lupus erythematosus:a blissless disease of too much BLyS(B lymphocyte stimulator)protein显示文摘	Stohl W Brady J R Chan B	2002	Curr Opin Rheumatol2002，14，：	1
15	Raised levels of anti-glucose-6- phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis显示文摘	Schaller M Stohl W Tan SM	2005	Ann Rheum Dis2005，64，5：	1
16	Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus显示文摘	Stohl W Metyas S Tan SM	2004	Ann Rheum Dis2004，63，9：	1
17	Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus显示文摘	STOHL W METYAS S TAN S M	2004	Ann Rheuma Dis2004，63，9：	1
18	Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus显示文摘	Petri M Stohl W Chatham W	2008	Arthritis Rheum2008，58，8：	1
19	B lymophcyte stimulator overexpression in patients with systemic lupus erythematosus显示文摘	Stohl W Metyas S Tan S M	2003	Arthritis Rheum2003，48，：	1
20	Biologic activity and safety of belimumab,a neutralizing anti-B-lymphocyte stimulator(BLyS)monoclonal antibody:A phase I trial in patients with systemic lupus erythematosus显示文摘	Furie R Stohl W Ginzler EM		0，，：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示